These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32966755)

  • 21. A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial.
    Birring SS; Wijsenbeek MS; Agrawal S; van den Berg JWK; Stone H; Maher TM; Tutuncu A; Morice AH
    Lancet Respir Med; 2017 Oct; 5(10):806-815. PubMed ID: 28923239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU).
    Tsianakas A; Zeidler C; Riepe C; Borowski M; Forner C; Gerss J; Metz M; Staubach P; Raap U; Kaatz M; Urban M; Luger TA; Ständer S
    Acta Derm Venereol; 2019 Apr; 99(4):379-385. PubMed ID: 30653242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy.
    Wortley MA; Adcock JJ; Dubuis ED; Maher SA; Bonvini SJ; Delescluse I; Kinloch R; McMurray G; Perros-Huguet C; Papakosta M; Birrell MA; Belvisi MG
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28931663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized, double-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier oncology group study.
    Albany C; Brames MJ; Fausel C; Johnson CS; Picus J; Einhorn LH
    J Clin Oncol; 2012 Nov; 30(32):3998-4003. PubMed ID: 22915652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial.
    Bakhshi S; Batra A; Biswas B; Dhawan D; Paul R; Sreenivas V
    Support Care Cancer; 2015 Nov; 23(11):3229-37. PubMed ID: 25851802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.
    Hesketh PJ; Grunberg SM; Gralla RJ; Warr DG; Roila F; de Wit R; Chawla SP; Carides AD; Ianus J; Elmer ME; Evans JK; Beck K; Reines S; Horgan KJ;
    J Clin Oncol; 2003 Nov; 21(22):4112-9. PubMed ID: 14559886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Theobromine inhibits sensory nerve activation and cough.
    Usmani OS; Belvisi MG; Patel HJ; Crispino N; Birrell MA; Korbonits M; Korbonits D; Barnes PJ
    FASEB J; 2005 Feb; 19(2):231-3. PubMed ID: 15548587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, double-blind, placebo-controlled study of aprepitant versus two dosages of olanzapine with ondansetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving high-emetogenic chemotherapy.
    Ithimakin S; Theeratrakul P; Laocharoenkiat A; Nimmannit A; Akewanlop C; Soparattanapaisarn N; Techawattanawanna S; Korphaisarn K; Danchaivijitr P
    Support Care Cancer; 2020 Nov; 28(11):5335-5342. PubMed ID: 32128615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial.
    Horton MR; Santopietro V; Mathew L; Horton KM; Polito AJ; Liu MC; Danoff SK; Lechtzin N
    Ann Intern Med; 2012 Sep; 157(6):398-406. PubMed ID: 22986377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Objectivation of the effect of antitussive agents using tussometry in patients with chronic cough].
    Matthys H; Erhardt J; Rühle KH
    Schweiz Med Wochenschr; 1985 Mar; 115(9):307-11. PubMed ID: 3885387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women: A Randomized Clinical Trial.
    Wang DS; Hu MT; Wang ZQ; Ren C; Qiu MZ; Luo HY; Jin Y; Fong WP; Wang SB; Peng JW; Zou QF; Tan Q; Wang FH; Li YH
    JAMA Netw Open; 2021 Apr; 4(4):e215250. PubMed ID: 33835174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II study of hydrocodone for cough in advanced cancer.
    Homsi J; Walsh D; Nelson KA; Sarhill N; Rybicki L; Legrand SB; Davis MP
    Am J Hosp Palliat Care; 2002; 19(1):49-56. PubMed ID: 12171425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitussive effect of a fixed combination of Justicia adhatoda, Echinacea purpurea and Eleutherococcus senticosus extracts in patients with acute upper respiratory tract infection: A comparative, randomized, double-blind, placebo-controlled study.
    Barth A; Hovhannisyan A; Jamalyan K; Narimanyan M
    Phytomedicine; 2015 Dec; 22(13):1195-200. PubMed ID: 26598919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of levodropropizine and dihydrocodeine on nonproductive cough in primary and metastatic lung cancer.
    Luporini G; Barni S; Marchi E; Daffonchio L
    Eur Respir J; 1998 Jul; 12(1):97-101. PubMed ID: 9701421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New medical technologies in cough therapy: results of a double-blind randomized placebo-controlled multicenter clinical trial].
    Polyakova EA; Ushakova SE; Okovityy SV; Zaytsev AA; Bagaeva MI
    Ter Arkh; 2024 Jul; 96(6):614-621. PubMed ID: 39106503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients.
    Takahashi T; Nakamura Y; Tsuya A; Murakami H; Endo M; Yamamoto N
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):653-9. PubMed ID: 21125277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRPV1 antagonists as potential antitussive agents.
    McLeod RL; Correll CC; Jia Y; Anthes JC
    Lung; 2008; 186 Suppl 1():S59-65. PubMed ID: 17926096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of antitussive efficacy of dextromethorphan in smoking related cough: objective vs. subjective measures.
    Ramsay J; Wright C; Thompson R; Hull D; Morice AH
    Br J Clin Pharmacol; 2008 May; 65(5):737-41. PubMed ID: 18279476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
    Warr DG; Grunberg SM; Gralla RJ; Hesketh PJ; Roila F; Wit Rd; Carides AD; Taylor A; Evans JK; Horgan KJ
    Eur J Cancer; 2005 Jun; 41(9):1278-85. PubMed ID: 15939263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.